Bob Lederer RBDR

2020 Research continuing innovation. Lieberman Rsch WW virtual reality breakthru. (RBDR 8.11.2015)

Today on RBDR: 1) A look at the continuing innovation push by 2020 Research, most recently for dial testing and an Apple Watch App specifically designed for market research. 2) Lieberman Research Worldwide has discovered the incredible power of Virtual Reality both for research and non-research situations. President David Sackman explained.

RBDR is sponsored by Precision Opinion, 100% FCC compliant with TCPA cell phone calling regulations. Can your CATI provider say that?

To find out the full implications, mostly notably those related to legal and cost, of TCPA compliance to a company and its research, please visit:

http://www.PrecisionOpinion.com/TCPA-Compliance/

Bob Lederer PRVR

FDA oversight of med devices questioned. What MDs want from Apple Watch (PMVR 10.13.2014)

To subscribe to PRVR and receive an email with multiple links to the latest video report, please click: http://ow.ly/Clawn

Pharma Research VIDEO Report, a co-partnered production with the Pharmaceutical Marketing Research Group, is sponsored this week by the Toluna Healthcare Practice, offering highly engaged physicians, health professionals and ailment sufferers for global research using cutting-edge methodologies, sophisticated, yet easy-to-use analytic tools and specialized products including Pharmacy Intercept, dedicated communities, patient record studies and more.

Find everything you could want to know about the Toluna Healthcare Practice at its homepage: http://www.toluna-group.com/about-toluna/industries-we-serve/healthcare/overview

On this PRVR: 1) Two separate studies call the FDA to task for its oversight of new medical devices. (http://articles.philly.com/2014-10-01/news/54479968_1_lower-risk-devices-regulating-medical-devices-the-fda)

2) An MD explains what physicians would like to see from new smart watches that the Apple Watch does not offer. (http://www.forbes.com/sites/robertpearl/2014/10/02/a-doctors-take-on-the-apple-watch/)

3) Psilos Group’s annual healthcare outlook recommends that healthcare insurers ditch their B2B model and focus on patients and providers. (http://www.mhealthnews.com/news/insurers-must-change-and-embrace-mhealth-survive)

4) The pharma profession is noticeably slow in adopting mobile technologies despite the industry’s rabid interest and desire for them. (http://www.mhealthnews.com/news/pharmas-tough-road-mobility)

5) Facebook is rumored to be developing two entries for the pharmaceutical and healthcare markets. (http://www.healthtechzone.com/topics/healthcare/articles/2014/10/06/390696-facebook-eying-healthcare.htm)

Bob Lederer RFL Communications, Inc.

Patient Identity theft, Fitbit, Apple Watch disgust, Hospital mistakes public (PRVR 9/15 – 19/2014)

Pharma Research VIDEO Report is sponsored by the Toluna Healthcare Practice, offering highly engaged physicians, health professionals and ailment sufferers for global research using cutting-edge methodologies, sophisticated, yet easy-to-use analytic tools and specialized products including Pharmacy Intercept, dedicated communities, patient record studies and more.

Toluna Healthcare Practice is recommending everyone read this Kaiser Family Foundation release for its emphasis on the growing importance of patients in industry research:

http://kff.org/health-costs/report/2014-employer-health-benefits-survey/

This week on PRVR: 1) The Boston Globe warns about the seriousness and dangers from stolen patient records. 2) Dick Vanderveer’s September 11 blog mentions FitBit’s legal right to sell data the device collects. 3) Federal regulators have decided to reverse course and begin making public records of eight hospital patient mistakes. 4) The Apple Watch introduction paid scant attention to healthcare. 5) India’s poor patent laws with Rx drugs are severely limiting the number of new drugs being made available there. 6) Big Data has brought at least four important benefits for healthcare.